PatientSafe Solutions, a US-based hospital safety company backed by local drugs group Merck’s corporate venturing unit, has raised $20m in its series C round.

Last month, PatientSafe said it had raised $13m, according to an updated filing with the Securities and Exchange Commission.

Merck’s Global Health Innovation (GHI) fund led the C round and was joined by existing venture investors, including Camden Partners, TPG Capital, and Psilos Group.

Maxwell Kahn, an investment principal at Merck GHI, has joined PatientSafe’s…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.

Not sure if you have a subscription?